cysteamine has been researched along with canavanine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
André, B; Anne, C; Aupetit, J; Chabli, A; Chadefaux-Vekemans, B; Debacker, C; Gasnier, B; Jézégou, A; Journet, A; Kieffer-Jaquinod, S; Llinares, E; O'Regan, S; Sagné, C | 1 |
1 other study(ies) available for cysteamine and canavanine
Article | Year |
---|---|
Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy.
Topics: Amino Acid Motifs; Amino Acid Sequence; Amino Acid Transport Systems, Basic; Animals; Base Sequence; Caenorhabditis elegans Proteins; Canavanine; Cysteamine; Cystinosis; DEAD-box RNA Helicases; DNA, Complementary; Drosophila Proteins; Electrophysiological Phenomena; Female; Genes, Fungal; Humans; Membrane Proteins; Molecular Sequence Data; Oocytes; Protein Structure, Secondary; Rats; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Species Specificity; Vacuoles; Xenopus laevis | 2012 |